This edition of RxInformer continues to monitor evolving trends in workers’ comp, from the increasing utilization of GLP-1 drugs, to drug shortages and their impact on claims, and how early pharmacy activity can signal claim risks.
High-impact drugs, including topicals and compounds, represent proportionately low utilization compared to opioids or NSAIDs, but they can increase pharmacy spend exponentially on impacted claims.
A current look at fraud, waste and abuse in workers’ comp pharmacy and medical services with strategies for management, including next-generation strategies involving AI.
Psychosocial factors impacting injured workers’ mental and behavioral health can be a barrier to recovery. But addressing any concerns early with the appropriate psychosocial treatments can positively affect a claim and health outcomes.
While everyone is affected by climate change, it’s often those on the front lines who feel it the most – those who work outdoors, in hot indoor environments, or in emergency response.
Explore the growing interest in research around psychedelic substances for medical applications related to workers' comp populations, including but not limited to: psilocybin, ketamine, MDMA
Receive twice annual email alerts when new issues are published!
RxInformer
Since 2010, the semi-annual RxInformer clinical journal has been a trusted source of timely information and guidance for workers’ comp payers on how best to manage the care of injured worker claimants and plan for the challenges that lay ahead. The publication is an important part of Healthesystems’ proactive approach to advocating for quality care of injured workers while managing the costs associated with treatment.
